$3.090
-0.326 (-10.56%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
VRCA Prediction & Forecast by Similar Chart Analysis
Alphio's VRCA stock price prediction model matches the current Verrica Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $3.20 (-0.37%). The 1-week path is $3.25 (+1.40%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Verrica Pharmaceuticals Inc Stock?
Verrica Pharmaceuticals Inc is a good buy right now due to its current price of $3.21, which is significantly below the analyst price targets of $9 and $12. The company has shown a gross margin of 85.02% in Q2 2026, indicating strong potential for profitability as it continues to develop its product YCANTH. However, the main risk is its recent performance, with a year-to-date change of -61.33%, reflecting significant volatility and financial pressure.
VRCA stock price ended at $3.09 on Thursday, after losing -10.56%
Verrica Pharmaceuticals Inc (VRCA) last closed at $3.21, gaining +3.88%. These facts feed the 1-day and 1-week VRCA price prediction above.
Analyst Consensus
Verrica Pharmaceuticals Inc (VRCA): 3 buy, 0 hold, 0 sell. Outlook: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Verrica Pharmaceuticals Inc (VRCA) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches VRCA, ranked by similarity.
Seasonality analysis for VRCA
Historically the probability of a positive November return for VRCA is 2.27%. July offers the highest probability of a positive month at 51.52%, while March is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for VRCA
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Nov 2026 | $0.18 | $0.28 | $0.37 | -91.13% |
| Dec 2026 | $0.26 | $0.42 | $0.48 | -86.94% |
In 2026, Verrica Pharmaceuticals Inc (VRCA) is projected to range from $0.18 to $0.48.
Verrica Pharmaceuticals Inc 2026 monthly forecast
In Nov 2026, Verrica Pharmaceuticals Inc is projected to average $0.28, with a low of $0.18 and high of $0.37.
In Dec 2026, Verrica Pharmaceuticals Inc is projected to average $0.42, with a low of $0.26 and high of $0.48.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.